Evidence map›Paper›PMID 39964661›Full record

ArticleNeurology and therapy2025

Prolonged Hospital Length of Stay Does Not Improve Functional Outcome in Acute Ischemic Stroke.

Yuxuan Lu, Peng Sun, Haiqiang Jin, Zhaoxia Wang, Zhiyuan Shen, Wei Sun, Yongan Sun, Ran Liu, Fan Li, Junlong Shu and 6 more

Registry-linked trialAbstract read
In one paragraph

Article in Neurology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02470624 (Chinese Acute Ischemic Stroke Treatment Outcome Registry), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02470624 unknown statusnot on this map

Chinese Acute Ischemic Stroke Treatment Outcome Registry

Typeobservational_patient_registrySponsorPeking University First HospitalRan2015 to 2017Enrolled10,000ConditionsIschemic StrokeArmstreatment following current guideline
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yuxuan Lu *Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Peng Sun *Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Haiqiang JinDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Zhaoxia WangDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Zhiyuan ShenDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Wei SunDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Yongan SunDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Ran LiuDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Fan LiDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Junlong ShuDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Zifeng QiuDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
Zhongbing LuCollege of Life Sciences, University of Chinese Academy of Science, Beijing, 100049, China.
Weiping SunDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China. sunweiping@bjmu.edu.cn.
Sainan ZhuDepartment of Biostatistics, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China. zhusainan77@163.com.
Yining HuangDepartment of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.
CASTOR Investigators

Funding

National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital) 2023IR29Scientific Research Seed Fund of Peking University First Hospital 2024SF10the Interdisciplinary Clinical Research Project of Peking University First Hospital 2021CR37the National Natural Science Foundation of China 81971115the National Natural Science Foundation of China 82071306
6 · The paper itself

Abstract

introductionIschemic stroke is the second leading cause of mortality and a major contributor to disability worldwide. Hospital length of stay (LOS) is a marker of medical efficiency for stroke care. There is limited information on this issue in China. This study aimed to identify predictors of prolonged LOS and to assess whether a prolonged LOS benefits functional outcomes in patients with acute ischemic stroke (AIS) in China.

methodsThis secondary analysis of the Chinese Acute Ischemic Stroke Treatment Outcome Registry, a multicenter, prospective, hospital-based registry study, included patients diagnosed as AIS and admitted to a hospital within 3 days after AIS onset from May 2015 to October 2017. Participants were dichotomized as the normal LOS group (LOS ≤ 14 days) and the prolonged LOS group (LOS > 14 days). The outcomes were the proportions of poor outcome at 3 months and 12 months after stroke onset. Poor outcome was defined as a mRS score of 3-6.

resultsThis study included 8171 patients (median age 64.0 years; 5367 male, 2804 female); 2968 (36.3%) patients had a prolonged LOS. Multivariable analysis identified independent predictors of prolonged LOS, including medical insurance, history of diabetes mellitus, stroke severity, use of anticoagulant agents, in-hospital infection complications, hemorrhagic events, and hospital region. A prolonged LOS was associated with a higher risk of poor outcome at 3 and 12 months after stroke, with this finding upheld in a propensity score-matched cohort as well as subgroup analyses stratified by stroke severity and age.

conclusionIn this study, approximately one-third of patients with AIS experienced a prolonged LOS over 14 days. Independent predictors of prolonged LOS included medical insurance, history of diabetes mellitus, stroke severity, use of anticoagulant agents, in-hospital infection complications, hemorrhagic events, and hospital region. Extending the LOS beyond 14 days did not enhance the prognosis for patients with AIS. As an observational study, our research provided the foundation for further interventional studies. Graphical abstract available for this article.

trial registrationClinicalTrials.gov NCT02470624.

Indexed as

Acute ischemic strokeFunctional outcomeHospital length of stay

Identifiers

PMID39964661
PMCPMC11906935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.